Missed the Congress ? NO Problem

metastatic urothelial carcinoma (mUC)

If you're focusing on this Category and want to learn from the best, then check out the content we have for you.

Meet our Speakers

We've gathered some of the top experts in the field to discuss this topic. With years of experience between them, they're well-equipped to offer invaluable insights and perspectives.

Prof. CI Weimin

Prof. CI Weimin

Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China

Talks

Single-cell atlases link macrophages and CD8+ T-cell in immunotherapy response in urothelial carcinoma

06 May 2023, 12:00 PM
Prof. CI Weimin

Junshi Biosciences

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

Hemosure

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Want to sponsor this event? Contact Us